by Jon A. Fredrickson Vice President, Chief Innovation Officer
If you only look at the data, it would appear that modern innovation is in a very poor state. Despite 84% of global executives saying innovation is important to their organization, nearly every single one of them, a full 94%, say they are dissatisfied with their innovation performance, according to a recent McKinsey poll. Thankfully, innovation is alive and well, mostly thanks to organizations who are willing to take one key step: opening up their innovation efforts to outside partners.
One of InnoCentive’s most recent challenges has successfully come to an end with resounding success. Seven awards were given out by the Green Chemistry & Commerce Council (GC3) to solvers from our global network. The GC3 is made up of members that include 11 consumer packaged goods (CPG) companies, two major retailers and five suppliers:
InnoCentive recently partnered with the ALS Association and Teva Pharmaceutical Industries Ltd. (“Teva”) to create and release a premium challenge aimed at helping find treatments for people with neurodegenerative diseases like Amyotrophic lateral sclerosis (ALS). InnoCentive has previously awarded Solvers over $1M for solutions in the field of ALS research.